In 2013, the International Agency for Research on Cancer (IARC) classified dioxin-like PCBs as human carcinogens.
According to the U.S. EPA, PCBs have been shown to cause cancer in animals and evidence supports a cancer-causing effect in humans. Per the EPA, studies have found increases in malignant melanoma and rare liver cancers in PCB workers.
In 2013, the IARC determined that the evidence for PCBs causing non-Hodgkin lymphoma is "limited" and "not consistent". In contrast an association between elevated blood levels of PCBs and non-Hodgkin lymphoma had been previously accepted. PCBs may play a role in the development of cancers of the immune system because some tests of laboratory animals subjected to very high doses of PCBs have shown effects on the animals' immune system, and some studies of human populations have reported an association between environmental levels of PCBs and immune response.